It is unclear how polyethylene glycol (PEG) laxatives compare with other classes of laxative
in terms of efficacy. To assess efficacy of PEG vs. placebo and active comparators in adults …

OBJECTIVES Polyethylene glycol (PEG) 3350 (MiraLAX) is currently approved for the short-
term treatment of occasional constipation. This study was designed to compare the safety …

Objective: The objective of this study was to evaluate in an analytical and descriptive
manner the evidence published so far on the use of polyethylene glycol (PEG), with or …

Background Polyethylene glycol is commonly used to manage constipation and is available
with or without electrolytes. The addition of electrolytes dates back to its initial development …

Aim: To compare standard and maximum daily doses of polyethylene glycol 3350 plus
electrolytes (Transipeg) and polyethylene glycol 4000 (Forlax) in a multicentre, double …

Constipation is a common childhood complaint. In 90% to 95% of children, constipation is
functional, which means that there is no objective evidence of an underlying pathological …

Abstract Background Polyethylene glycol 3350 (MiraLAX, Braintree Laboratories Inc.,
Braintree, MA, USA) is approved for the short‐term treatment of occasional constipation. Aim …

Background Constipation is a common clinical problem. Lactulose and Polyethylene Glycol
(PEG) are both commonly used osmotic laxatives that have been shown to be effective and …

BACKGROUND: Constipation is an uncomfortable and common condition that affects many,
irrespective of age. Since 1500 BC and before, health care practitioners have provided …

OBJECTIVE Polyethylene glycol (PEG) 3350 (MiraLax) and tegaserod (Zelnorm), a
serotonin subtype 4 receptor partial agonist, are currently approved for treatment of …